Advertisement

2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague

2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague

Teladoc Health (NYSE: TDOC) sank 74% last year -- and for one particular reason. The telemedicine giant reported two billion-dollar noncash goodwill impairment charges. Both were linked to the acquisition of chronic-care specialist Livongo.